Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease

被引:13
作者
Von Bargen, Emily C. [1 ,2 ]
Grimes, Cara L. [3 ]
Mishra, Kavita [4 ]
Wang, Rui [2 ,5 ]
Haviland, Miriam J. [2 ,5 ]
Hacker, Michele R. [2 ,5 ]
Carnevale, Joseph A. [4 ]
Estes, Alyssa J. [6 ]
Elkadry, Eman A. [1 ,2 ]
机构
[1] Harvard Med Sch, Mt Auburn Hosp, Dept Obstet & Gynecol, Cambridge, MA 02238 USA
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY USA
[4] Brown Univ, Dept Obstet & Gynecol, Providence, RI 02912 USA
[5] Harvard Med Sch, Boston, MA USA
[6] Touro Coll Osteopath Med, New York, NY USA
基金
美国国家卫生研究院;
关键词
Fibroids; Hysterectomy; Morcellation; Myomectomy; Uterine malignancy; HYSTERECTOMY; CANCER;
D O I
10.1002/ijgo.12111
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine the prevalence of occult pre-malignant or malignant uterine pathology at the time of laparoscopic surgery with open power morcellation for benign gynecologic disease. Methods: The present multicenter, retrospective cohort study included women who underwent open power morcellation for benign indications between January 1, 2007, and February 28, 2014, at three academic medical centers in the USA. The primary outcome was pre-malignant or malignant pathology at the time of open power morcellation, and was determined from the patients' pathology reports. Results: During the study period, 1214 women underwent open power morcellation for benign indications. Similar preoperative characteristics were observed between patients with normal pathology and those with pre-malignant or malignant uterine pathology, including body mass index, parity, hypertension, diabetes, breast cancer, and smoking (all P > 0.129). Among patients who underwent open power morcellation, 14 (1.2%) had occult pre-malignant or malignant pathology; 5 (0.4%) women had endometrial adenocarcinoma and 1 (0.1%) had low-grade endometrial stromal sarcoma. There were eight patients with malignant pathology who underwent additional surgical exploration and were disease free at their final clinical visit, with a median follow-up time of 42.0months (interquartile range 5.0-62.0 months). Conclusion: Endometrial adenocarcinoma and low-grade endometrial stromal sarcoma were rare in the present study and there were no reports of leiomyosarcoma.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 15 条
[1]  
[Anonymous], UPDATED LAP UT POW M
[2]  
[Anonymous], AM J OBSTET GYNECOL
[3]   The utility of preoperative endometrial sampling for the detection of uterine sarcomas [J].
Bansal, Nisha ;
Herzog, Thomas J. ;
Burke, William ;
Cohen, Carmel J. ;
Wright, Jason D. .
GYNECOLOGIC ONCOLOGY, 2008, 110 (01) :43-48
[4]   Chlorhexidine-alcohol compared with povidone-iodine for surgical-site antisepsis after abdominal hysterectomy [J].
Bazzi, A. ;
Harris, J. ;
Morgan, D. ;
Pearlman, M. D. ;
Reynolds, R. ;
Campbell, D. A. ;
Uppal, S. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (04) :S463-S463
[5]   Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH) [J].
Bojahr, Bernd ;
De Wilde, Rudy Leon ;
Tchartchian, Garri .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 292 (03) :665-672
[6]   Uterine sarcomas: A review [J].
D'Angelo, Emanuela ;
Prat, Jaime .
GYNECOLOGIC ONCOLOGY, 2010, 116 (01) :131-139
[7]   Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease [J].
Einstein, M. H. ;
Barakat, R. R. ;
Chi, D. S. ;
Sonoda, Y. ;
Alektiar, K. M. ;
Hensley, M. L. ;
Abu-Rustum, N. R. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (05) :1065-1070
[8]   Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support [J].
Harris, Paul A. ;
Taylor, Robert ;
Thielke, Robert ;
Payne, Jonathon ;
Gonzalez, Nathaniel ;
Conde, Jose G. .
JOURNAL OF BIOMEDICAL INFORMATICS, 2009, 42 (02) :377-381
[9]   Cost-effectiveness analysis of annual screening strategies for endometrial cancer [J].
Havrilesky, Laura J. ;
Maxwell, G. Larry ;
Myers, Evan R. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (06) :640.e1-640.e8
[10]  
Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI [10.3322/caac.20006, 10.3322/caac.21254, 10.3322/caac.21332, 10.3322/caac.21551, 10.3322/caac.20073, 10.3322/caac.21387, 10.3322/caac.21654, 10.3322/caac.21601]